Evoke Pharma Inc.
4.26
0.03 (0.71%)
At close: Jan 14, 2025, 3:58 PM
4.31
1.17%
After-hours Jan 14, 2025, 03:59 PM EST

Balance Sheet (Annual)

Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11
Cash & Equivalents 4.74M 9.84M 9.14M 8.07M 5.66M 5.32M 7.68M 9.01M 8.69M 14.16M 24.20M 116.01K 865.88K
Short-Term Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets 241.64K -129.07K -12.43K 11.55K 11.55K 11.55K 11.55K 11.55K 8.00K 53.02K 555.50K n/a n/a
Receivables 673.07K 624.83K 295.19K 23.31K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Inventory 481.84K 289.38K 185.53K 236.48K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets 932.57K 964.50K 935.30K 952.06K 581.71K 329.22K 251.05K 275.71K 833.28K 1.09M 234.26K n/a 39.46K
Total Current Assets 6.83M 11.72M 10.56M 9.28M 6.25M 5.65M 7.93M 9.28M 9.52M 15.25M 24.43M 116.01K 905.34K
Property-Plant & Equipment n/a 129.07K 12.43K 141.71K 138.54K n/a n/a n/a n/a n/a n/a n/a n/a
Goodwill & Intangibles n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets 241.64K 129.07K 12.43K 153.26K 150.09K 11.55K 11.55K 11.55K 8.00K 53.02K 555.50K n/a n/a
Total Assets 7.07M 11.85M 10.57M 9.43M 6.40M 5.66M 7.94M 9.29M 9.53M 15.30M 24.99M 116.01K 905.34K
Account Payables 1.71M 868.31K 874.03K 1.27M 1.03M 476.20K 1.05M 478.22K 927.61K 989.63K 284.92K 96.80K n/a
Deferred Revenue n/a n/a n/a n/a -1.03M n/a n/a n/a -927.61K -989.63K -284.92K n/a n/a
Short-Term Debt 5.00M 258.15K 24.86K 245.87K 277.08K n/a n/a n/a 146.05K 150.43K 1.44M n/a n/a
Other Current Liabilities 2.94M 528.08K 506.89K 6.02M 704.62K 1.16M 1.03M 933.45K 760.78K 731.56K 557.40K 473.61K 334.50K
Total Current Liabilities 9.65M 1.65M 1.41M 7.54M 2.02M 1.63M 2.07M 1.41M 1.83M 1.87M 2.28M 570.41K 334.50K
Long-Term Debt 5.00M 5.00M 5.00M 5.00M n/a n/a n/a n/a 4.23M 4.24M 1.51M 979.79K n/a
Other Long-Term Liabilities 1.61M 1.11M 612.29K 112.99K n/a n/a 3.70M 4.10M n/a n/a 6.83K 18.23M n/a
Total Long-Term Liabilities 6.61M 6.11M 5.61M 5.11M n/a n/a 3.70M 4.10M 4.23M 4.24M 1.52M 19.20M 18.23M
Total Liabilities 9.65M 7.77M 7.02M 12.65M 2.02M 1.63M 5.78M 5.51M 6.07M 6.11M 3.80M 19.78M 18.56M
Total Debt 5.00M 5.13M 5.01M 5.25M 138.54K n/a n/a n/a 4.38M 4.39M 2.95M 979.79K n/a
Common Stock 334.00 334.00 3.27K 2.66K 2.44K 1.74K 1.54K 1.24K 720.00 611.00 610.00 124.00 124.00
Retained Earnings -123.44M -115.65M -107.42M -98.89M -85.73M -78.60M -71.04M -58.81M -48.06M -35.94M -22.69M -19.86M -17.84M
Comprehensive Income n/a n/a n/a -0.00 n/a 0.00 0.00 n/a -0.00 n/a -24.99M -18.23M n/a
Shareholders Equity -2.58M 4.08M 3.56M -3.21M 4.38M 4.03M 2.17M 3.79M 3.46M 9.19M 21.18M -19.66M -17.65M
Total Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a